MedPath

Phase I/II trial of Nedaplatin/S-1 combination followed by maintenance S-1 therapy in advanced Squamous Cell Lung Cancer

Phase 1
Recruiting
Conditions
Advanced Squamous Cell Lung Cancer
Registration Number
JPRN-UMIN000009399
Lead Sponsor
Department of Medical Oncology, Kinki University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

History of active other malignancy Severe heart disease Severe complication Intestinal pneumonia or lung fibrosis Severe diarrhea Massive pleural, cardiac, or abdominal effusion Regular use of fenitoin, warfarin or frucitocin Symptomatic brain metastasis History of severe drug allergic reaction Pregnant women or women willing child bearing Inadequate condition diagnosed by primary physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath